| INSMED INC. DL-,01 |
| USA |
| Gesundheit |
| US4576693075 / A1JJA3 |
| IM8N (Frankfurt) / INSM (NASDAQ) |
| FRA:IM8N, ETR:IM8N, IM8N:GR, NASDAQ:INSM |
| - |
| https://insmed.com/ |
|
Insmed Inc. is a biopharmaceutical company dedicated to enhancing the lives of patients with rare diseases. The company's primary focus is on the development and commercialization of treatments for se..
>Volltext.. |
| 26812.51 Mio. EUR |
| 26014.6 Mio. EUR |
| 377.81 Mio. EUR |
| -825.44 Mio. EUR |
| -1000.54 Mio. EUR |
| -5.22 EUR |
| 629.72 Mio. EUR |
| 282.93 Mio. EUR |
| -746.62 Mio. EUR |
| 4.03 |
| 23.68% |
| -29.97% |
| - |
| - |
| - |
| INSMED |
| 19.02.26 |